---
schema_version: "secwatch.filing_event.v1"
accession: "0001285550-23-000048"
form_type: "8-K"
ticker: "CLPT"
cik: "0001285550"
company_name: "ClearPoint Neuro, Inc."
filed_at: "2023-05-22T23:59:59+00:00"
generated_at: "2026-06-14T18:02:18.711390+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "medium"
source: SEC EDGAR
---

# ClearPoint Neuro amends director compensation plan effective May 22, 2023

## Summary
- Board approved revisions to non-employee director compensation plan; prior version dated May 21, 2022.
- Annual retainers: chair $75K, other directors $40K; committee chairs and members receive additional cash retainers.
- New directors receive RSU grant valued at $135K vesting in one year; annual RSU grant also $135K for continuing directors.
- Directors may elect to receive retainers in common stock in lieu of cash.

## SEC filing metadata
- accession: 0001285550-23-000048
- form_type: 8-K
- ticker: CLPT
- cik: 0001285550
- company_name: ClearPoint Neuro, Inc.
- filed_at: 2023-05-22T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: medium
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1285550/000128555023000048/0001285550-23-000048-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1285550/000128555023000048/clpt-20230522.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001285550-23-000048
- JSON: https://secwatch.observer/filing/0001285550-23-000048.json
- Plain text: https://secwatch.observer/filing/0001285550-23-000048.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.